CELGENE
Live / Registered — Registered and renewed (as of 20 Dec 2024)
What this means for you
Registered since 28 Sept 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Sept 2024).
Record
- Serial number
- 76515116
- Registration number
- 2888517
- Mark type
- Word mark
- Filed
- 19 May 2003
- Published for opposition
- 06 Jul 2004
- Registered
- 28 Sept 2004
- Next maintenance due
- 28 Sept 2024
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 001 — Chemicals: [ biochemical catalysts for use in medical research; biological preparations for medical purposes, namely, for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; [ enzyme preparations for industrial purposes; enzymes for industrial purposes; ] proteins for [ industrial and ] human consumption, namely, animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; [ chemical preparations used to protect crops in the agricultural and horticultural field; ] medicinal and biological preparations for medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system ]
- Class 005 — Pharmaceuticals: [ biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriogical culture media for medical use; medicinal and biological preparations for pharmaceutical and clinical use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system ]
- Class 040 — Treatment of materials: [ manufacturing pharmaceutical products for others; custom synthesis of DNA to the order and specification of others; custom manufacturing services, namely, manufacturing agrochemicals to the specification of others ]
- Class 041 — Education and entertainment services: [ educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith ]
- Class 042 — Scientific and technological services: research in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping base on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods for others [ ; agrochemical product development for others ]
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Warren, NJ, US
- Celgene Corporation, Warren, NJ, US
Prior registrations
Prosecution history
- 20 Dec 2024 — NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
- 20 Dec 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 20 Dec 2024 — REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
- 20 Dec 2024 — REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
- 20 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Sept 2024 — TEAS SECTION 8 & 9 RECEIVED
- 28 Sept 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Sept 2020 — NOTICE OF SUIT
- 20 Apr 2020 — NOTICE OF SUIT